Rubius Therapeutics, a cutting-edge biotech startup that’s creating “superblood” to treat conditions including cancer, has raised an extra $100 million to make its dream a reality.
The post Biotech startup is creating genetically engineered ‘superblood’ to battle cancer appeared first on Digital Trends.
from Emerging Tech–Digital Trends http://ift.tt/2FXVrB6
0 comments: